---
title: "Webinar: What’s in your gene therapy product? Rapid, comprehensive AAV genomic profiling made simple - with Oxford Nanopore - 11.06.2025"
description: What’s in your gene therapy product? Rapid, comprehensive AAV genomic profiling made simple - custom webinar with Oxford Nanopore Technologies - 11.06.2025
image: https://info.edifydigitalmedia.com/hubfs/Oxford-Nanopore-Landing-Page-Banner-0525_1425px.jpg
---

[![DDW-Logo](https://info.edifydigitalmedia.com/hs-fs/hubfs/DDW-Logo.png?width=239&height=121&name=DDW-Logo.png "DDW-Logo")](https://www.edifydigitalmedia.com/)

![Oxford-Nanopore-Landing-Page-Banner-0525\_1425px](https://info.edifydigitalmedia.com/hubfs/Oxford-Nanopore-Landing-Page-Banner-0525_1425px.jpg "Oxford-Nanopore-Landing-Page-Banner-0525_1425px")

Webinar  
What’s in your gene therapy product? Rapid, comprehensive AAV genomic profiling made simple

 

 

 

![DDW\_Oxford-Nanopore\_Event\_Logo\_400px\_Cropped-2](https://info.edifydigitalmedia.com/hs-fs/hubfs/DDW_Oxford-Nanopore_Event_Logo_400px_Cropped-2.jpg?width=400&height=111&name=DDW_Oxford-Nanopore_Event_Logo_400px_Cropped-2.jpg)

---

 

![Oxford\_Nanopore\_webinar\_speakers\_image\_200px](https://info.edifydigitalmedia.com/hubfs/Oxford_Nanopore_webinar_speakers_image_200px.jpg "Oxford_Nanopore_webinar_speakers_image_200px")

As the field of gene therapy advances, the need for fast, accurate, and scalable characterisation of adeno-associated virus (AAV) products and the plasmids used to produce them has never been greater.

 

Join Oxford Nanopore Technologies and Plasmidsaurus for an expert-led webinar, hosted by DDW, showcasing new and improved genomics solutions for gene therapy development and vector quality control. Throughout the session, you’ll hear real-world case studies where gene therapy teams have applied this solution to characterise vector impurities, resolve historically challenging DNA motifs such as inverted terminal repeats (ITRs), and accelerate vector development.

 

This session will introduce an updated sequencing workflow that delivers deeper insights into AAV products, helping to identify and clarify critical quality attributes often missed by alternative sequencing methods, and providing results in just days, not weeks.

 

Developed by Plasmidsaurus, pioneers of overnight plasmid sequencing, and enabled by Oxford Nanopore Technologies’ real-time, single-molecule sensing platform, this solution provides unbiased characterisation of both single-stranded and self-complementary AAV genomes, offering researchers and manufacturing teams a powerful tool to reduce development risk and improve confidence in vector batch profiling.

 

**What you’ll learn:**

- How the rapid AAV genome sequencing workflow developed by Plasmidsaurus represents a significant improvement over alternative AAV sequencing methods
- How Oxford Nanopore sequencing technology offers major advantages over legacy short-read and alternative long-read platforms
- Why leading gene therapy teams are applying this solution to accelerate development, improve vector characterisation, and de-risk batch release

 A Q&A session follows the webinar presentations.

Watch the webinar on-demand now!

 

### Watch the Webinar

## Copyright 2022 Drug Discovery World. All Rights Reserved Privacy Policy & Cookies | Contact | Terms & Conditions